FNRN
Earnings company data as of 10:00 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by FNRN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $101K bought by 3 insiders
- $561K sold by 4 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Richard M Martinez DirectorSale$35K 2,000 shares at $17.51 2.7% of stakeTraded Aug 13 Filed Aug 14
-
Jean-Luc Servat DirectorBuy$17K 1,000 shares at $17.29 +22% to stakeTraded Aug 12 Filed Aug 12
-
Mark C Schulze DirectorSale$109K 6,368 shares at $17.12 0.9% of stakeTraded Aug 10–11 Filed Aug 12
-
Mark C Schulze DirectorSale$7,244 400 shares at $18.11 0.1% of stakeTraded Aug 6 Filed Aug 11
-
Jean-Luc Servat DirectorBuy$18K 1,000 shares at $18.22 +28% to stakeTraded Aug 5–6 Filed Aug 7
-
Mark C Schulze DirectorSale$59K 3,232 shares at $18.40 0.4% of stakeTraded Aug 4–5 Filed Aug 6
-
Jeremiah Zachary Smith CEOSale$120K 6,783 shares at $17.69 4.2% of stakeTraded May 15 Filed May 18
-
Mark C Schulze DirectorSale$36K 2,000 shares at $17.79 0.3% of stakeTraded May 12 Filed May 14
-
Mark C Schulze DirectorSale$53K 3,000 shares at $17.78 0.4% of stakeTraded May 8 Filed May 11
-
Kevin Spink CFOSale$141K 8,271 shares at $17.04 15% of stakeTraded May 4 Filed May 6
-
Barbara A Hayes DirectorBuy$2,514 171 shares at $14.70 +1.4% to stakeTraded Feb 18 Filed Feb 19
-
Jean-Luc Servat DirectorBuy$21K 1,463 shares at $14.58 +73% to stakeTraded Feb 18–19 Filed Feb 19
-
Jean-Luc Servat DirectorBuy$29K 2,000 shares at $14.49 New stakeTraded Feb 11–12 Filed Feb 12
-
Richard Bedoya DirectorBuy$13K 893 shares at $14.49 +44% to stakeTraded Feb 11 Filed Feb 12
Also filed in the last 12 months, not counted as buying or selling: 5 stock grants, 3 gifts, 2 share withholdings for taxes, and 2 option exercises.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| DEF 14A | FORM DEF 14A | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 10-K | FORM 10-K | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,8.01,9.01 | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.